-
Mashup Score: 0Medicare may plan to negotiate drug prices, but some states are taking their own steps to lower costs - 7 month(s) ago
A handful of states are moving aggressively to slash drug costs for their residents, a clear sign the battle over affordable medicines in the U.S. is only going to escalate further.
Source: www.statnews.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1Pharmalittle: Novo halts Ozempic kidney failure trial after early signs of success; GSK settles California Zantac lawsuit - 7 month(s) ago
Novo Nordisk plans to stop a trial of Ozempic to treat kidney failure after an interim analysis showed the drug would succeed.
Source: www.statnews.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Pharmalittle: Weight-loss drugs fuel boom for firms that fill syringes; employers that cover obesity drug may double in 2024 - 7 month(s) ago
Contract manufacturers are investing billions to expand or build factories to fill injection pens used to administer weight-loss treatments.
Source: www.statnews.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Is your Ozempic pen fake? FDA investigating counterfeit weight loss drugs, trade group says - 7 month(s) ago
The warning about scams comes as sales have boomed for Ozempic, Wegovy and other drugs used for weight loss.
Source: www.cbsnews.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Judge dismisses Novo Nordisk lawsuit over compounded versions of Ozempic and Wegovy - 7 month(s) ago
In a setback for Novo Nordisk, a U.S. judge dismissed its lawsuit accusing a compound pharmacy of selling versions of its Wegovy and Ozempic medicines,
Source: www.statnews.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0The Wegovy Shortage Drags On, Leaving Patients in Limbo - 7 month(s) ago
The situation has left many patients frustrated and unable to start taking the weight loss drug.
Source: www.nytimes.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Pharmalittle: FDA panel lacks confidence in Amgen cancer drug data; weight loss drugs linked to rare stomach problems - 7 month(s) ago
A FDA advisory panel voted 10-2 that the data for Amgen’s Lumakras lung cancer treatment could not be properly assessed.
Source: www.statnews.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Pharmalittle: Novo faces patent challenge on Wegovy and Ozempic; Senate panel moves to address drug shortages - 7 month(s) ago
A U.S. Patent Office tribunal agreed to review the validity of a Novo Nordisk patent related to its blockbuster drugs Ozempic and Wegovy.
Source: www.statnews.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
Some analysts are questioning whether Amgen was fully forthcoming about a pricey lung cancer drug that is supposed to generate key revenue growth.
Source: www.statnews.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Pharmalittle: FDA finds ‘potential systemic bias’ in Amgen cancer drug trial; drugmakers organize to push back on antitrust reviews - 7 month(s) ago
A study of Amgen’s Lumakris may reflect systemic biases, the FDA said ahead of a meeting to determine whether the drug should stay on the market.
Source: www.statnews.comCategories: General Medicine News, Latest HeadlinesTweet
Medicare may plan to negotiate drug prices, but some states are taking their own steps to lower costs.. https://t.co/53Pgl7IzcM #pharma #Medicare #medicine #prescriptions #Maryland #Minnesota #Michigan #Colorado $VRTX